Open Government Canada
Guidance Document: Information and Submission Requirements for Biosimilar Biologic Drugs
Published by Health Canada | Santé Canada
About this dataset
This guidance document applies to all biologic drug submissions where the sponsor seeks authorization for sale based on demonstrated similarity to a previously approved biologic drug and relies, in part, on prior information regarding that biologic drug in order to present a reduced clinical and non-clinical package as part of the submission.